Bolt Biotherapeutics, Inc. ( BOLT) - Stock Earnings
BOLT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.1 million USD | 2.2 million USD |
| 2025Q4 | -6.6 million USD | 2.5 million USD |
| 2026Q1 | -7.2 million USD | 26000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BOLT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -69.2 million USD | 7.9 million USD |
| 2024 | -63.1 million USD | 7.7 million USD |
| 2025 | -33.4 million USD | 7.7 million USD |
| 2026 Est. | — | — |
BOLT
Price: $3.99
52 week price:
Earnings Per Share: -17.85 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 121100
Market Capitalization: 9.1 million